These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 2866032

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New antitumor imidazole derivative, 5-carbamoyl-1H-imidazol-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphoribosyltransferase.
    Fukui M, Inaba M, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1982 Mar; 42(3):1098-102. PubMed ID: 6120758
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Collateral sensitivity to N-(phosphonacetyl)-L-aspartic acid in a line of P388 leukemia cells selected for resistance to L-(alpha S, 5S)-alpha-amino-3- chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Ardalan B, Jayaram HN, Johnson RK.
    Cancer Res; 1983 Apr; 43(4):1598-601. PubMed ID: 6831405
    [Abstract] [Full Text] [Related]

  • 8. [Antitumor activities of orally administered 4-carbamoylimidazolium-5-olate (SM-108)].
    Nakamura M, Fukui M, Morisada S, Inaba M, Tsukagoshi S, Sakurai Y.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2030-6. PubMed ID: 4051519
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biochemical characteristics of a 5-fluorouracil-resistant subline of P388 leukemia.
    Tezuka M, Sugiyama H, Tamemasa O, Inaba M.
    Gan; 1982 Feb; 73(1):70-6. PubMed ID: 7117749
    [Abstract] [Full Text] [Related]

  • 16. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ, Pawlak K, Nguyen BT, Robins RK, Sadée W.
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.
    Ahluwalia GS, Cohen MB, Kang GJ, Arnold ST, McMahon JB, Dalal M, Wilson YA, Cooney DA, Balzarini J, Johns DG.
    Cancer Res; 1986 Sep; 46(9):4479-85. PubMed ID: 2425954
    [Abstract] [Full Text] [Related]

  • 19. Role of the adenylate deaminase reaction in regulation of adenine nucleotide metabolism in Ehrlich ascites tumor cells.
    Chapman AG, Miller AL, Atkinson DE.
    Cancer Res; 1976 Mar; 36(3):1144-50. PubMed ID: 943236
    [Abstract] [Full Text] [Related]

  • 20. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
    Dekker K, Kojima N, Yamamoto S, Tatsumi K, Mino M, Yagi K.
    Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.